FAQ/Help |
Calendar |
Search |
Today's Posts |
03-05-2018, 10:19 PM | #1 | ||
|
|||
Member
|
Phase 2 Trial Testing Leukemia Treatment, Nilotinib
Phase 2 Trial Testing Leukemia Treatment, Nilotinib, in Range of Parkinson's Patients - Parkinson's News Today |
||
Reply With Quote |
"Thanks for this!" says: | Tupelo3 (03-06-2018) |
03-06-2018, 09:26 PM | #2 | ||
|
|||
Member
|
Quote:
|
||
Reply With Quote |
03-08-2018, 02:10 PM | #3 | ||
|
|||
Member
|
Tupelo,
I wasn't seriously considering enrolling in this trial, but I am curious how the independenr group buyers of Nilotinib have fared. If any of you are reading this let us know how things are going. Best, Eric |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Treatment completed for all patients in LCT's NTCELL Phase IIb trial (New Zealand) | Parkinson's Disease | |||
Recruitment has begun for the Georgetown University "PD Nilotinib" phase 2 trial | Parkinson's Disease | |||
inhaled l-dopa - Civitas starts Phase 2a trial of Parkinson’s treatment | Parkinson's Disease | |||
Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lat | ALS News & Research |